Top Authors

• Most frequent coverage on PARD

• 
  Philip Davis (5914 followers)

  • Options Trader: Monday Market Movement (Mon, Dec 7)
  • Two Week Wrap-Up: Trading Both Ends of Our Range (Mon, Dec 7)
  • Weak Weekly Market Wrap-Up: Primed for a Correction (Mon, Nov 23)

  More by Philip Davis on PARD »
• 
  Frederic Ruffy (602 followers)

  • Tuesday Options Recap: Put-Call Ratio Leaders (Tue, Dec 15)
  • Tuesday Options Recap (Tue, Nov 17)
  • Monday Options Recap (Mon, Nov 16)

  More by Frederic Ruffy on PARD »
• 
  Alan Brochstein (712 followers)

  • Cancer Stocks Hammered Once Again (Tue, Jun 26)
  • Cancer Stocks Slide Again (Mon, Jun 18)
  • Cancer Stocks Plunge Following ASCO Meeting (Mon, Jun 11)

  More by Alan Brochstein on PARD »

• Most followed authors on PARD

• 
  Philip Davis (5914 followers)

  • Options Trader: Monday Market Movement (Mon, Dec 7)
  • Two Week Wrap-Up: Trading Both Ends of Our Range (Mon, Dec 7)
  • Weak Weekly Market Wrap-Up: Primed for a Correction (Mon, Nov 23)

  More by Philip Davis on PARD »
• 
  Mike Havrilla (1946 followers)

  • BioMed News Bytes: Cytori, Poniard, Alkermes, Spherix, CRXX, HGSI (Tue, Nov 17)
  • FDA Calendar: 2H09 Binary Event Trades (Mon, Jul 27)
  • Pending Clinical Trial Results: Ten Extreme Trades (Thu, May 14)

  More by Mike Havrilla on PARD »
• 
  Alan Brochstein (712 followers)

  • Cancer Stocks Hammered Once Again (Tue, Jun 26)
  • Cancer Stocks Slide Again (Mon, Jun 18)
  • Cancer Stocks Plunge Following ASCO Meeting (Mon, Jun 11)

  More by Alan Brochstein on PARD »

• Newest authors on PARD

• 
  Ivan Mutaftchiev (6 followers)

  • Azimuth Opportunity Bets on Poniard's Survival (Wed, Nov 25)

  More by Ivan Mutaftchiev on PARD »
• 
  Justin M. Hall (671 followers)

  • Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers (Sun, Sep 20)
  • Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up (Fri, Sep 11)

  More by Justin M. Hall on PARD »
• 
  M. E. Garza (522 followers)

  • Big Lineup of Healthcare Stocks Crack the Russell 3000 Index (Wed, Jul 1)
  • Healthcare Stocks Sluggish as Some Say Recent Rally Is Over (Tue, Jun 16)

  More by M. E. Garza on PARD »

• Most commented on PARD

• 
  Justin M. Hall (671 followers)

  • Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers (Sun, Sep 20)
  • Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up (Fri, Sep 11)

  More by Justin M. Hall on PARD »
• 
  Philip Davis (5914 followers)

  • Options Trader: Monday Market Movement (Mon, Dec 7)
  • Two Week Wrap-Up: Trading Both Ends of Our Range (Mon, Dec 7)
  • Weak Weekly Market Wrap-Up: Primed for a Correction (Mon, Nov 23)

  More by Philip Davis on PARD »
• 
  Ohad Hammer (176 followers)

  • Rigel Pharmaceuticals: Biotech Crisis or Opportunity? (Mon, Nov 10)
  • 'When There's Blood in the Streets', Buy Biotech Stocks (Fri, Oct 10)
  • Poniard Pharmaceuticals: Platinum Rediscovered (Part II) (Tue, Jun 24)

  More by Ohad Hammer on PARD »